Montana Molecular, founded in Bozeman, US, is dedicated to advancing drug discovery and research through the development of innovative fluorescent biosensors and reporters. Their core mission is to enhance scientific understanding and facilitate breakthroughs in biomedical research. The company offers a range of products and services, including cell-based assays, ligand bias detection, multiplex assays, and custom assay development. They also specialize in BacMam production, live cell assays, and cell stress sensors, focusing on providing high-quality tools for researchers in the pharmaceutical and biotechnology sectors.
Notable figures associated with Montana Molecular include experts in biosensor technology and drug discovery, although specific names are not provided. The company has achieved significant milestones in developing reliable and effective biosensors that have been widely adopted in research institutions and pharmaceutical companies. Their impact is evident in the enhanced accuracy and efficiency of drug discovery processes, contributing to the development of new therapies and medical advancements. Montana Molecular continues to be a pivotal player in the field of biomedical research tools.
Quick Facts
When was Montana Molecular's last funding round?
Montana Molecular's most recent funding round was for $692.4k (USD) in November 2014.
How much disclosed funding has Montana Molecular raised?
As of Nov 26, 2014, Montana Molecular has disclosed funding of $2M (USD).
